Executive Summary
Mito Red Light, Inc. challenged Joovv, Inc.'s patent (11253719) in the PTAB, arguing that the claims are obvious under 35 U.S.C. § 103. The petitioner relies heavily on prior art references including Dijkstra and Norwood to demonstrate obviousness in photobiomodulation therapy systems.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Mito Red Light, Inc. vs Joovv, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Luxottica of America Inc. et al.vsE-Vision Optics, LLC
The PTAB found all 19 challenged claims unpatentable based on obviousness (35 U.S.C. § 103). The Petitioner successfully demonstrated that combinations of prior art references, such as Howell-596 and Howell-158, rendered the claimed features in smart eyeglasses obvious to a Person Having Ordinary Skill in the Art (POSITA).
Samsung Electronics Co., Ltd. et al.vsStaton Techiya LLC
The PTAB granted institution of IPR for Samsung against Staton Techiya regarding U.S. Patent 11,610,587, focusing on audio management and sonic signature detection.
Ericsson Inc. et al.vsXR COMMUNICATIONS LLC
Ericsson and Nokia's IPR petition against XR Communications LLC was denied by the PTAB, failing to demonstrate a reasonable likelihood of success on obviousness grounds. The Board found that the petitioner did not persuasively show that prior art constituted 'pre-equalization.'
Shenzhen Waydoo Intelligence Technology Co., Ltd.vsMHL Custom, Inc.
The PTAB denied an Inter Partes Review petition against MHL Custom's patent (9586659) filed by Shenzhen Waydoo Intelligence. The denial was based on the petition being time-barred under 35 U.S.C. § 315(b), as Petitioner had already lost related litigation using the same prior art.
Samsung Electronics Co., Ltd. et al.vsOura Health Oy et al.
Samsung Electronics challenged Oura Health's patent claims in a PGR proceeding, arguing obviousness and anticipation. The PTAB found the vast majority of the grounds unpersuasive, but ultimately cancelled two dependent claims (17 and 18) under § 112(d).
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.